{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:02:52Z","timestamp":1791295372528,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["U54AI-065357"],"award-info":[{"award-number":["U54AI-065357"]}]},{"name":"Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2012.03.003","type":"journal-article","created":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T14:30:32Z","timestamp":1331649032000},"page":"3180-3187","source":"Crossref","is-referenced-by-count":41,"title":["A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain"],"prefix":"10.1016","volume":"30","author":[{"given":"Brett A.","family":"Thibodeaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina C.","family":"Garbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Roehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.03.003_bib0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0010","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.vaccine.2005.03.002","article-title":"Yellow fever vaccination: how much is enough","volume":"23","author":"Massad","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0015","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4269\/ajtmh.2001.65.954","article-title":"Inadequate protection against yellow fever of children visiting endemic areas","volume":"66","author":"Potasman","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tmaid.2005.02.001","article-title":"Late vaccination against yellow fever of travelers visiting endemic countries","volume":"4","author":"Krief","year":"2006","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/JCM.38.5.1827-1831.2000","article-title":"Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay","volume":"38","author":"Johnson","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10408360490497474","article-title":"Yellow fever: the recurring plague","volume":"41","author":"Tomori","year":"2004","journal-title":"Clin Rev Clin Lab Sci"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0035","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0040","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0045","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2008.05.004","article-title":"Closing the door on flaviviruses: entry as a target for antiviral drug design","volume":"80","author":"Perera","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","article-title":"Molecular targets for flavivirus drug discovery","volume":"81","author":"Sampath","year":"2009","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1099\/0022-1317-67-2-229","article-title":"Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever by dengue 2 viruses","volume":"67","author":"Brandriss","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0065","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.135.4.2805","article-title":"Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48","volume":"135","author":"Schlesinger","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0070","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/320199","article-title":"Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies","volume":"183","author":"Tesh","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000614","article-title":"A mouse model for studying viscerotropic disease caused by yellow fever virus infection","volume":"5","author":"Meier","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0080","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0085","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.69.8.4792-4796.1995","article-title":"Antiviral defense in mice lacking both alpha\/beta and gamma interferon receptors","volume":"69","author":"Van den Broek","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0090","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.02509-07","article-title":"E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence","volume":"82","author":"Lee","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/CVI.00354-08","article-title":"Development of a human-murine chimeric IgM antibody for use in the serological detection of human flavivirus antibodies","volume":"16","author":"Thibodeaux","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0100","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1111\/j.1749-6632.2009.05057.x","article-title":"A mouse model for studying dengue virus pathogenesis and immune response","volume":"1171","author":"Williams","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0110","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/425016","article-title":"Activation of cytokine network and unfavorable outcome in patients with yellow fever","volume":"190","author":"ter Meulen","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mvr.2006.08.002","article-title":"Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells","volume":"73","author":"Takahashi","year":"2007","journal-title":"Microvasc Res"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0125","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0130","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1128\/JVI.05298-11","article-title":"Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence","volume":"85","author":"Stein","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0135","first-page":"285","article-title":"Pathophysiology","volume":"vol. 5","author":"Halstead","year":"2008"},{"key":"10.1016\/j.vaccine.2012.03.003_bib0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: an update","volume":"1","author":"Monath","year":"2001","journal-title":"Lancet Inf Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12003489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12003489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T02:22:23Z","timestamp":1687314143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12003489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":28,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0264410X12003489"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}